Regarded as the gold standard in cytocentrifugation, Cytospin is used in thousands of laboratories and a range of applications, and is cited extensively in published papers around the world.
The legacy of the Epredia Cytospin is long – from the launch of the very first Shandon Cytospin in 1967 to the Epredia Cytospin 4 in the present day, as the cover story in the August issue of Pathology in Practice illustrates (see page 23)
The extensive Epredia portfolio of high-quality instruments, consumables and microscope slides facilitates the efficient processing and accurate diagnosis of precious patient specimens.
Epredia was established in July 2019 from the acquisition by the PHC Group of the Anatomical Pathology Division of Thermo Fisher Scientific. Powered by the trusted legacybrands such as Shandon, Microm and Menzel Gläser, Epredia has a wide breadth of solutions that will continue to transform the anatomical pathology market.
The quality products that you know and trust are now fully Epredia branded. The name has changed but the mission remains the same, to improve lives by enhancing precision cancer diagnostics.